{
    "Trade/Device Name(s)": [
        "BD Veritor\u2122 System for Rapid Detection of Flu A + B CLIA Waived Kit",
        "BD Veritor\u2122 System",
        "BD Veritor\u2122 System Flu A + B"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K152870",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112277",
        "K132259",
        "K132692",
        "K151291"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "September 29, 2015",
    "Summary Letter Received Date": "September 30, 2015",
    "Submission Date": "September 28, 2015",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "immunology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Veritor\u2122 System Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Rapid chromatographic immunoassay",
        "Immunochromatographic assay"
    ],
    "Methodologies": [
        "Qualitative antigen detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Reader",
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for BD Veritor System for Rapid Detection of Flu A + B CLIA waived kit for qualitative detection of influenza A and B nucleoprotein antigens in respiratory specimens",
    "Indications for Use Summary": "A rapid chromatographic immunoassay for direct and qualitative detection of influenza A and B viral nucleoprotein antigens from nasal and nasopharyngeal swabs of symptomatic patients, aiding in diagnosis of influenza A and B viral infections.",
    "fda_folder": "Microbiology"
}